ANDES-AGI-1067

· AtheroGenics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANDES-AGI-1067, covering 2008-02-06 to 2008-02-06. Get the full timeline:

Most recent: Clinical Trial Update: ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study [Phase 2, Phase 3]